<?xml version="1.0" encoding="UTF-8"?>
<ref id="B65-vaccines-07-00179">
 <label>65.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Zhang</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Vogt</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Oliphant</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Engle</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bovshik</surname>
    <given-names>E.I.</given-names>
   </name>
   <name>
    <surname>Diamond</surname>
    <given-names>M.S.</given-names>
   </name>
   <name>
    <surname>Beasley</surname>
    <given-names>D.W.</given-names>
   </name>
  </person-group>
  <article-title>Development of resistance to passive therapy with a potently neutralizing humanized monoclonal antibody against West Nile virus</article-title>
  <source>J. Infect. Dis.</source>
  <year>2009</year>
  <volume>200</volume>
  <fpage>202</fpage>
  <lpage>205</lpage>
  <pub-id pub-id-type="doi">10.1086/599794</pub-id>
  <pub-id pub-id-type="pmid">19527169</pub-id>
 </element-citation>
</ref>
